Your browser is no longer supported. Please, upgrade your browser.
Settings
OSUR OraSure Technologies, Inc. daily Stock Chart
OSUR [NASD]
OraSure Technologies, Inc.
Index- P/E33.53 EPS (ttm)0.52 Insider Own2.70% Shs Outstand56.17M Perf Week15.64%
Market Cap971.74M Forward P/E56.91 EPS next Y0.30 Insider Trans-53.83% Shs Float55.89M Perf Month16.58%
Income29.70M PEG1.68 EPS next Q0.07 Inst Own92.60% Short Float6.53% Perf Quarter35.90%
Sales131.70M P/S7.38 EPS this Y142.90% Inst Trans16.25% Short Ratio4.46 Perf Half Y97.71%
Book/sh3.67 P/B4.71 EPS next Y-27.27% ROA14.10% Target Price15.30 Perf Year164.12%
Cash/sh2.49 P/C6.96 EPS next 5Y20.00% ROE16.10% 52W Range5.57 - 15.90 Perf YTD97.04%
Dividend- P/FCF35.99 EPS past 5Y31.00% ROI10.60% 52W High8.81% Beta1.57
Dividend %- Quick Ratio9.20 Sales past 5Y9.40% Gross Margin66.90% 52W Low210.59% ATR0.50
Employees325 Current Ratio9.90 Sales Q/Q11.70% Oper. Margin25.40% RSI (14)78.53 Volatility4.33% 3.21%
OptionableYes Debt/Eq0.00 EPS Q/Q385.30% Profit Margin22.60% Rel Volume4.72 Prev Close15.72
ShortableYes LT Debt/Eq0.00 EarningsAug 02 AMC Payout0.00% Avg Volume817.54K Price17.30
Recom1.40 SMA2013.11% SMA5019.23% SMA20062.23% Volume3,861,512 Change10.05%
Feb-09-17Upgrade Raymond James Mkt Perform → Outperform
Jun-13-16Downgrade Raymond James Outperform → Mkt Perform
Nov-05-15Reiterated Mizuho Buy $12 → $8
May-07-15Downgrade JMP Securities Mkt Outperform → Mkt Perform
Jan-23-15Reiterated Mizuho Buy $10 → $12
Jun-12-14Reiterated Canaccord Genuity Buy $10 → $11
Jun-11-14Reiterated Mizuho Buy $9 → $10
Dec-21-12Initiated Mizuho Buy $9
Aug-08-12Upgrade Barrington Research Mkt Perform → Outperform $12.50
Jul-05-12Downgrade Barrington Research Outperform → Mkt Perform
Mar-27-12Initiated JMP Securities Mkt Outperform $15
Mar-21-12Upgrade MLV & Co Hold → Buy $11 → $13
Feb-09-12Downgrade MLV & Co Buy → Hold $11
Jul-01-11Resumed Barrington Research Outperform $10
Nov-30-10Initiated Barrington Research Outperform $8
Nov-16-10Initiated Canaccord Genuity Buy $8
Nov-17-09Upgrade Needham Hold → Buy $5.50
May-04-09Reiterated FBR Capital Markets Mkt Perform $17 → $16
Jun-20-08Downgrade Needham Buy → Hold
May-07-08Reiterated Susquehanna Financial Positive $12 → $10
Jun-27-17 06:25PM  Why OraSure Technologies, Inc. Jumped Higher Today Motley Fool +10.05%
04:30PM  Why OraSure Technologies, Baytex Energy, and Handy & Harman Jumped Today Motley Fool
06:00AM  OraSure Technologies to Drive Accelerated Adoption of OraQuick® HIV Self-Test GlobeNewswire
Jun-22-17 06:00AM  OraSure Technologies Appoints Mara G. Aspinall to Board of Directors GlobeNewswire
Jun-19-17 03:53PM  ETFs with exposure to OraSure Technologies, Inc. : June 19, 2017 Capital Cube
Jun-08-17 01:51PM  ETFs with exposure to OraSure Technologies, Inc. : June 8, 2017 Capital Cube
Jun-06-17 08:39AM  OraSure Technologies, Inc. :OSUR-US: Earnings Analysis: Q1, 2017 By the Numbers : June 6, 2017 Capital Cube
08:24AM  5 Top Performing Efficient Stocks to Buy Now Zacks
May-31-17 06:00AM  OraSure Technologies to Present at the Jefferies 2017 Global Healthcare Conference GlobeNewswire
May-24-17 05:00PM  Edited Transcript of OSUR earnings conference call or presentation 3-May-17 9:00pm GMT Thomson Reuters StreetEvents
May-22-17 09:30AM  Zacks.com featured highlights: Baxter International, Lantheus Holdings, OraSure Technologies, MAM Software Group and Teradyne Zacks
May-19-17 09:40AM  5 Top Efficient Stocks to Add to Your Portfolio Zacks
May-18-17 08:40AM  Why OraSure (OSUR) Could Be an Impressive Growth Stock Zacks
May-16-17 06:00AM  OraSure Technologies to Present at the UBS Global Healthcare Conference GlobeNewswire
May-10-17 06:00AM  OraSure Technologies to Hold Virtual Annual Meeting of Stockholders GlobeNewswire
May-07-17 08:10PM  Edited Transcript of OSUR earnings conference call or presentation 3-May-17 9:00pm GMT Thomson Reuters StreetEvents
May-05-17 02:31PM  OraSure Technologies, Inc.: Leads amongst peers with strong fundamentals Capital Cube
May-04-17 04:52PM  Why OraSure Technologies, Inc. Jumped Higher Today Motley Fool +18.40%
May-03-17 05:01PM  OraSure posts 1Q profit Associated Press
04:00PM  OraSure Announces 2017 First Quarter Financial Results GlobeNewswire
09:35AM  Investor Network: OraSure Technologies, Inc. to Host Earnings Call Accesswire
Apr-17-17 09:49AM  Abbott Laboratories Agrees to Acquire Alere at Lower Price Zacks
Apr-12-17 06:00AM  OraSure Technologies Earnings Conference Call Invitation GlobeNewswire
Apr-10-17 04:22PM  Zimmer Biomet (ZBH) Upgraded to Hold on Solid Prospects Zacks
10:11AM  Medtronic Initiates Product Recall, A Drag on Neurosurgery Zacks
10:05AM  VWR Corp Continues its Acquisition Spree with MESM Buyout Zacks
Apr-07-17 09:29AM  Medtronic (MDT) Less-Invasive HVAD Pump Results Positive Zacks
Apr-06-17 09:47AM  Medtronic HVAD System Results Positive for Long-Term Therapy Zacks
08:50AM  IDEXX Laboratories' CAG Revenues Solid, Competition Rife Zacks
Apr-04-17 09:03AM  Walgreens, Prime Form Central Specialty & Mail Service Company Zacks
Apr-03-17 09:03AM  NuVasive Receives FDA 510(k) Clearance in Cervical Spine Zacks
Mar-31-17 01:52PM  Boston Scientific (BSX) Inks Agreement to Acquire Symetis SA Zacks
09:44AM  Abbott's St Jude Buyout to Boost Business, Risks Remain
Mar-30-17 09:47AM  Genomic Health's GPS Predicts Metastatic Prostate Cancer Zacks
09:13AM  NuVasive (NUVA) Gets FDA 510(k) Clearance for CoRoent System Zacks
08:49AM  QIAGEN Offers JAK2 Kit in US, Grows in Molecular Diagnostics Zacks
08:49AM  QIAGEN Offers JAK2 Kit in US, Grows in Molecular Diagnostics at Investopedia
Mar-29-17 09:25AM  Integra LifeSciences Expands Cadence System Commercially Zacks
Mar-24-17 09:30AM  Zacks Industry Outlook Highlights: Quidel, OraSure Technologies, ResMed, Inogen and Masimo Zacks
Mar-22-17 09:30AM  Today's Research Reports on Stocks to Watch: OraSure Technologies and Sunshine Heart Accesswire
08:25AM  OraSure Technologies (OSUR) In Focus: Stock Jumps 8.4%
Mar-21-17 05:00PM  Why Chipotle Mexican Grill, Sprouts Farmers Markets, and OraSure Technologies Jumped Today at Motley Fool +8.36%
Mar-20-17 06:36PM  OraSure Technologies and John B. Sanfilippo & Son Set to Join S&P SmallCap 600 PR Newswire
09:30AM  Zacks.com featured highlights: American Woodmark, Heska, OraSure Technologies, Pioneer Natural Resources and Advanced Energy Industries
Mar-18-17 01:04PM  ORASURE TECHNOLOGIES INC Financials
Mar-17-17 11:44AM  Top 5 Efficient Stocks to Buy Right Now
11:30AM  Medical Device Company's Growth Driven By One-Time Gain at Forbes
Mar-14-17 04:13PM  ORASURE TECHNOLOGIES INC Files SEC form 10-K, Annual Report
Mar-10-17 09:30AM  The Zacks Analyst Blog Highlights: Inogen, OraSure Technologies, Lannett and Cardiovascular Systems
Mar-02-17 09:30AM  Zacks.com featured highlights: Teradyne, Advanced Energy Industries, Lululemon Athletica, Bovie Medical and OraSure Technologies
Mar-01-17 08:46AM  5 Best Efficient Stocks to Buy in March
06:00AM  OraSure Receives Global Fund Classification to Enable HIV Self-Test Procurement GlobeNewswire
Feb-27-17 10:27AM  Top Ranked Momentum Stocks to Buy for February 27th
06:00AM  OraSure Technologies to Present at the Raymond James 38th Annual Institutional Investors Conference GlobeNewswire
Feb-24-17 09:19AM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi
06:00AM  OraSure Technologies Announces Director Retirement GlobeNewswire
Feb-17-17 08:39AM  Surging Earnings Estimates Signal Good News for OraSure (OSUR)
Feb-16-17 09:30AM  Zacks.com featured highlights: Rush Enterprises, Louisiana-Pacific, Alliance Resource Partners, Teradyne and OraSure Technologies
Feb-15-17 11:25AM  OraSure Technologies, Inc. :OSUR-US: Earnings Analysis: Q4, 2016 By the Numbers : February 15, 2017
Feb-13-17 09:30AM  Zacks.com featured highlights: Brooks Automation, United States Steel, Everest Re Group, OraSure Technologies and Soffa Industries and TTM Technologies
Feb-10-17 05:00PM  OraSure Technologies, Inc.: Leads amongst peers with strong fundamentals
02:04PM  OraSure Technologies, Inc. :OSUR-US: Earnings Analysis: 2016 By the Numbers : February 10, 2017
08:30AM  Want to Gain from Relative Price Strength? 5 Stocks to Buy
Feb-09-17 01:35PM  Why OraSure Technologies, Inc. Leaped Higher Today at Motley Fool +18.53%
11:45AM  3 Quiet Earnings Reports Making the Biggest Moves on Thursday
06:34AM  OraSure upgraded by Raymond James
Feb-08-17 10:02PM  Edited Transcript of OSUR earnings conference call or presentation 8-Feb-17 10:00pm GMT
05:11PM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure,
05:00PM  OraSure Technologies Inc Earnings Call scheduled for 5:00 pm ET today
04:32PM  OraSure posts 4Q profit
04:00PM  OraSure Announces 2016 Fourth Quarter and Full-Year Financial Results GlobeNewswire
07:07AM  Q4 2016 OraSure Technologies Inc Earnings Release - 4:00 pm ET
Feb-06-17 07:55AM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
06:00AM  OraSure Technologies Announces Settlement of Litigation with Ancestry.comDNA GlobeNewswire
Feb-01-17 07:26AM  OraSure Technologies, Inc. breached its 50 day moving average in a Bullish Manner : OSUR-US : February 1, 2017
Jan-31-17 09:38AM  AmerisourceBergen (ABC) Q1 Earnings Beat, Revenues Lag
Jan-30-17 09:30AM  Zacks.com featured highlights: OraSure Technologies, Union Pacific, LyondellBasell Industries, Advanced Energy Industries and Rollins
08:20AM  Hill-Rom (HRC) Q1 Earnings Meet, Revenues Lag Estimates
Jan-27-17 08:38AM  Abaxis (ABAX) Q3 Bleak: Earnings In Line, Revenues Miss
08:12AM  Cardiovascular Systems (CSII) Q2 Earnings Better Estimates
Jan-26-17 03:24PM  Mead Johnson (MJN) Misses Q4 Earnings, Sales; Guides '17
09:45AM  Quest Diagnostics (DGX) Tops Q4 Earnings, Offers '17 View
06:43AM  PetMed (PETS) Lags Q3 Earnings Estimates, Tops Revenues
Jan-25-17 11:00AM  Abbott Labs (ABT) Tops Q4 Earnings Estimates, Sales In Line
Jan-24-17 08:12AM  ResMed (RMD) Beats Earnings and Revenue Estimates in Q2
Jan-23-17 12:16PM  OraSure Technologies, Inc. Value Analysis (NASDAQ:OSUR) : January 23, 2017
Jan-20-17 08:30AM  OraSure Technologies, Inc. breached its 50 day moving average in a Bearish Manner : OSUR-US : January 20, 2017
Jan-11-17 06:00AM  OraSure Technologies Earnings Conference Call Invitation GlobeNewswire
Dec-09-16 01:32PM  Is Progenics Pharmaceuticals, Inc. (PGNX) a Good Stock to Buy? at Insider Monkey
Dec-01-16 04:21PM  OraSure Stock Sets Up For Buy Point On Hep C Contract, Helix Win
Nov-29-16 01:29PM  Hedge Funds Are Unsure of OraSure Technologies, Inc. (OSUR) at Insider Monkey
08:22AM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits
06:00AM  OraSure to Implement $18 Million Product Supply Contract From Foreign Government for HCV Elimination Program GlobeNewswire
06:00AM  Helix Selects DNA Genoteks Oragene® Collection Device and GenoFIND Fulfillment Services for Genetic Discovery Applications GlobeNewswire
Nov-28-16 10:00AM  OraSure Technologies, Inc. (Nasdaq: OSUR) to Ring The Nasdaq Stock Market Opening Bell GlobeNewswire -5.49%
Nov-21-16 06:00AM  OraSure Technologies to Host Analyst Day GlobeNewswire
Nov-15-16 08:40AM  ORASURE TECHNOLOGIES INC Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhi
06:00AM  OraSure Technologies Appoints Stephen S. Tang, Ph.D. as Chairman of the Board of Directors GlobeNewswire
Nov-14-16 07:56AM  OraSure Technologies, Inc. breached its 50 day moving average in a Bullish Manner : OSUR-US : November 14, 2016
Nov-09-16 06:00AM  OraSure Technologies to Present at the 10th Annual Canaccord Genuity Medical Technology & Diagnostics Forum GlobeNewswire
OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, and sells oral fluid diagnostic products and specimen collection devices in the United States, Europe, and internationally. It operates in two segments, OSUR and DNAG. The company also offers other diagnostic products, such as immunoassays and other in vitro diagnostic tests. Its principal products include OraQuick ADVANCE HIV-1/2, OraQuick HIV1/2, OraQuick HIV self-test, OraQuick HCV, OraQuick In-Home HIV test, OraQuick Ebola, OraQuick Zika, OraSure QuickFlu rapid flu A&B test, OraSure, Oragene DX, Oragene DNA, Oragene RNA, ORAcollect, OMNIgene DISCOVER, Performagene LIVESTOCK and Oragene ANIMAL, OMNIgene GUT, OMNIgene SPUTUM, PrepIT MAX, OMNIgene VAGINAL, OMNIgene ORAL, PrepIT, Intercept, MICRO-PLATE DOA assays, Intercept i2, homogeneous DOA assays, and professional and over-the-counter cryosurgical systems. In addition, the company offers oral fluid collection devices to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, pharmacogenomics, personalized medicine, microbiome and animal genetics, and academic research markets. Further, it provides medical devices for the removal of benign skin lesions by cryosurgery or freezing; immunoassay tests and reagents for insurance risk assessment, substance abuse testing, and forensic toxicology applications; an oral fluid Western blot HIV-1 confirmatory test for confirming positive HIV-1 test; and Q.E.D. rapid point-of-care saliva alcohol test. The company markets its products to clinical laboratories, hospitals, clinics, community-based organizations, public health organizations, distributors, government agencies, physicians' offices, commercial and industrial entities, retail pharmacies, mass merchandisers, and consumers. OraSure Technologies, Inc. was founded in 1979 and is based in Bethlehem, Pennsylvania.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
SPAIR RONALD HCOO & CFOMay 31Option Exercise5.6150,000280,364159,066Jun 02 07:59 PM
SPAIR RONALD HCOO & CFOMay 31Sale15.0650,000752,890109,066Jun 02 07:59 PM
LANCASTER RONNY BDirectorMay 30Option Exercise8.0615,000120,82521,295May 30 04:55 PM
Patrick Charles WDirectorMay 30Sale15.156,666100,99052,104May 30 04:56 PM
LANCASTER RONNY BDirectorMay 30Sale15.0715,000225,9756,295May 30 04:55 PM
LANCASTER RONNY BDirectorMay 26Sale14.7374,6841,100,3946,295May 30 04:55 PM
Zezzo II AnthonyEVP, Marketing and SalesMay 10Option Exercise5.94115,000682,525260,410May 11 05:30 PM
Zezzo II AnthonyEVP, Marketing and SalesMay 10Sale14.70115,0001,690,845145,410May 11 05:30 PM
Michels Douglas APresident & CEOMay 09Option Exercise5.80209,8001,217,564977,858May 11 05:29 PM
Michels Douglas APresident & CEOMay 09Sale15.01209,8003,149,098768,058May 11 05:29 PM
KUNA MARK LSVP & ControllerMay 08Option Exercise6.727,00047,05768,793May 09 06:46 PM
Michels Douglas APresident & CEOMay 08Option Exercise6.91247,6541,711,232935,974May 09 06:48 PM
SPAIR RONALD HCOO & CFOMay 08Option Exercise5.196,50033,735115,566May 09 06:53 PM
SPAIR RONALD HCOO & CFOMay 08Sale15.036,50097,695109,066May 09 06:53 PM
Michels Douglas APresident & CEOMay 08Sale15.09247,6543,737,099768,058May 09 06:48 PM
KUNA MARK LSVP & ControllerMay 08Sale15.007,000105,00063,491May 09 06:46 PM
KUNA MARK LSVP & ControllerMay 05Option Exercise7.0529,413207,21592,904May 09 06:46 PM
PRINGLE ROGER LDirectorMay 05Option Exercise4.81140,552675,664217,004May 09 06:50 PM
Michels Douglas APresident & CEOMay 05Option Exercise6.63113,562752,348881,620May 09 06:48 PM
SPAIR RONALD HCOO & CFOMay 05Option Exercise5.1966,064342,872175,130May 09 06:53 PM
SPAIR RONALD HCOO & CFOMay 05Sale15.0066,064990,960109,066May 09 06:53 PM
PRINGLE ROGER LDirectorMay 05Sale14.93140,5522,098,86376,452May 09 06:50 PM
KUNA MARK LSVP & ControllerMay 05Sale15.1329,413445,01963,491May 09 06:46 PM
Patrick Charles WDirectorMay 05Sale14.969,255138,4550May 09 06:49 PM
Patrick Charles WDirectorMay 05Sale14.9674511,14556,881May 09 06:49 PM
Michels Douglas APresident & CEOMay 05Sale15.06113,5621,710,244768,058May 09 06:48 PM
Celano MichaelDirectorMay 05Sale14.9544,962672,18238,117May 09 06:45 PM
TANG STEPHEN S PHDDirectorMar 21Sale12.002202,64031,748Mar 23 04:41 PM
Celano MichaelDirectorMar 02Option Exercise8.0615,000120,82598,079Mar 06 05:05 PM
Celano MichaelDirectorMar 02Sale12.0015,000180,00083,079Mar 06 05:05 PM
TANG STEPHEN S PHDDirectorMar 02Sale12.026,10073,34631,968Mar 06 05:02 PM
Patrick Charles WDirectorFeb 28Sale11.2713,880156,41460,076Mar 01 03:38 PM
Patrick Charles WDirectorFeb 28Sale11.305,65063,8459,255Mar 02 04:22 PM
Patrick Charles WDirectorFeb 27Sale11.3016,003180,88473,956Mar 01 03:38 PM
SPAIR RONALD HCOO & CFOFeb 16Sale11.1250,000555,780150,063Feb 16 05:33 PM
JERRETT JACK ESVP & General CounselFeb 15Option Exercise6.47107,288694,218163,130Feb 16 05:31 PM
TANG STEPHEN S PHDDirectorFeb 15Option Exercise8.2140,000328,20078,068Feb 16 05:34 PM
TANG STEPHEN S PHDDirectorFeb 15Sale11.0440,000441,75638,068Feb 16 05:34 PM
JERRETT JACK ESVP & General CounselFeb 15Sale11.06107,2881,186,47758,842Feb 16 05:31 PM
SPAIR RONALD HCOO & CFOFeb 14Option Exercise2.812,9268,207118,314Feb 15 05:03 PM
SPAIR RONALD HCOO & CFOFeb 14Sale10.659,24898,449109,066Feb 15 05:03 PM
SPAIR RONALD HCOO & CFOFeb 13Option Exercise2.8115,79444,302169,860Feb 15 05:03 PM
SPAIR RONALD HCOO & CFOFeb 13Sale10.5954,472576,897115,388Feb 15 05:03 PM
KUNA MARK LSVP & ControllerFeb 10Option Exercise6.1964,271397,973127,762Feb 13 04:38 PM
KUNA MARK LSVP & ControllerFeb 10Sale10.7564,271690,78563,491Feb 13 04:38 PM
Michels Douglas APresident & CEOFeb 09Option Exercise4.07193,355786,501961,413Feb 13 04:39 PM
TANG STEPHEN S PHDDirectorFeb 09Sale10.2312,641129,29238,068Feb 13 04:41 PM
Michels Douglas APresident & CEOFeb 09Sale10.21193,3551,974,271768,058Feb 13 04:39 PM
KUNA MARK LSVP & ControllerFeb 09Sale10.0015,000150,00063,491Feb 13 04:38 PM
Celano MichaelDirectorFeb 09Sale10.0610,000100,60083,079Feb 13 04:37 PM
PRINGLE ROGER LDirectorFeb 01Option Exercise8.2815,000124,12550,476Feb 02 07:04 PM
SPAIR RONALD HCOO & CFOFeb 01Option Exercise8.2845,000372,375154,066Feb 02 06:32 PM
Patrick Charles WDirectorFeb 01Option Exercise8.2815,000124,12589,959Feb 02 06:22 PM
LANCASTER RONNY BDirectorFeb 01Option Exercise8.2815,000124,12578,603Feb 02 06:19 PM
Celano MichaelDirectorJan 31Option Exercise8.2815,000124,125108,079Feb 02 06:14 PM
Celano MichaelDirectorJan 31Sale8.7815,000131,70093,079Feb 02 06:14 PM
SPAIR RONALD HCOO & CFOJan 17Sale8.713,34129,103160,810Jan 19 05:02 PM
KUNA MARK LSVP & ControllerDec 15Option Exercise8.0610,00080,55082,965Dec 16 04:56 PM
KUNA MARK LSVP & ControllerDec 15Sale9.3010,00093,00072,965Dec 16 04:56 PM
Michels Douglas APresident & CEODec 13Option Exercise8.1071,466579,006803,364Dec 14 09:07 PM
KUNA MARK LSVP & ControllerDec 13Option Exercise8.2117,000139,57589,965Dec 14 09:09 PM
KUNA MARK LSVP & ControllerDec 13Sale9.1117,000154,85072,965Dec 14 09:09 PM
Michels Douglas APresident & CEODec 13Sale9.0771,466647,998731,898Dec 14 09:07 PM
KUNA MARK LSVP & ControllerDec 09Option Exercise8.283,00024,82575,965Dec 12 01:02 PM
Michels Douglas APresident & CEODec 09Option Exercise8.2823,891197,698755,789Dec 12 12:46 PM
KUNA MARK LSVP & ControllerDec 09Sale9.033,00027,09072,965Dec 12 01:02 PM
JERRETT JACK ESVP & General CounselNov 23Option Exercise8.1724,000195,96072,105Nov 25 05:53 PM
KUNA MARK LSVP & ControllerNov 23Option Exercise2.867,13120,42095,096Nov 25 05:55 PM
Michels Douglas APresident & CEONov 23Option Exercise8.285,89348,765737,791Nov 28 07:29 PM
Michels Douglas APresident & CEONov 23Sale9.0230,893278,711731,898Nov 28 07:29 PM
KUNA MARK LSVP & ControllerNov 23Sale9.027,13164,32272,965Nov 25 05:55 PM
JERRETT JACK ESVP & General CounselNov 23Sale9.0024,000216,00048,105Nov 25 05:53 PM
KUNA MARK LSVP & ControllerNov 22Option Exercise5.1915,00077,85087,965Nov 25 05:55 PM
KUNA MARK LSVP & ControllerNov 22Sale8.8815,000133,24580,096Nov 25 05:55 PM
Michels Douglas APresident & CEOSep 26Sale8.2225,000205,525756,898Sep 28 05:40 PM
Patrick Charles WDirectorAug 31Sale8.5817,483150,00414,905Aug 31 05:24 PM
JERRETT JACK ESVP & General CounselAug 30Option Exercise4.7936,415174,529116,791Aug 31 05:26 PM
JERRETT JACK ESVP & General CounselAug 30Sale8.5268,686585,42248,105Aug 31 05:26 PM
Patrick Charles WDirectorAug 29Sale8.942,25020,11574,959Aug 31 05:24 PM
Patrick Charles WDirectorAug 05Sale7.246,57547,60377,209Aug 31 05:24 PM